3.10. Treatment with FGF401, FGFR4-Specific Inhibitor, Enhances Sensitivity to Carboplatin of SORL1-Expressing Ovarian Cancer in Xenograft Mouse Model. This evidence concerns the gene SORL1 and ovarian carcinoma.